Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-020175
Filing Date
2020-08-04
Accepted
2020-08-04 16:26:11
Documents
7
Period of Report
2020-08-03

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea124927-6k_tizianalife.htm 6-K 22126
2 OPINION OF ORRICK, HERRINGTON & SUTCLIFFE (UK) LLP ea124927ex5-1_tizianalife.htm EX-5.1 83485
3 PLACEMENT AGENCY AGREEMENT DATED AUGUST 2, 2020 ea124927ex10-1_tizianalife.htm EX-10.1 76301
4 FORM OF SECURITIES PURCHASE AGREEMENT ea124927ex10-2_tizianalife.htm EX-10.2 236828
5 PRESS RELEASE, DATED AUGUST 3, 2020 ea124927ex99-1_tizianalife.htm EX-99.1 24685
6 GRAPHIC image_001.jpg GRAPHIC 2364
7 GRAPHIC image_002.jpg GRAPHIC 2364
  Complete submission text file 0001213900-20-020175.txt   451248
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences plc (Filer) CIK: 0001723069 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 201073670
SIC: 2834 Pharmaceutical Preparations